4.5 Article

Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure

Journal

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 114, Issue -, Pages 253-263

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2017.11.020

Keywords

Atrium; Hypertensive heart disease; Left ventricular hypertrophy; Heart failure; Contractility; Calcium

Funding

  1. European Commission [EUTRAF - 261057]

Ask authors/readers for more resources

Hypertensive heart disease (HHD) can cause left ventricular (LV) hypertrophy and heart failure (HF). It is unclear, though, which factors may contribute to the transition from compensated LV hypertrophy to HF in HHD. We hypothesized that maladaptive atrial remodeling with impaired atrial myocyte function would occur in advanced HHD and may be associated with the emergence of HF. Experiments were performed on atrial myocytes and tissue from old (15-25 months) normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) with advanced HHD. Based on the absence or presence of elevated lung weight, a sign of lung congestion and heart failure, SHR were divided into a non-failing (SHR-NF) and failing (SHR-HF) group. Compared with WKY, SHR exhibited elevated blood pressure, LV hypertrophy and left atrial (LA) hypertrophy with increased LA expression of markers of hypertrophy and fibrosis. SHR-HF were distinguished from SHR-NF by aggravated hypertrophy and fibrosis. SHR-HF atrial myocytes exhibited reduced contractility and impaired SR Ca2+ handling. Moreover, in SHR the expression and phosphorylation of SR Ca2+-regulating proteins (SERCA2a, calsequestrin, RyR2 and phospholamban) showed negative correlation with increasing lung weight. Increasing stimulation frequency (1-2-4 Hz) of atrial myocytes caused a progressive increase in arrhythmogenic Ca2+ release (including altemans), which was observed most frequently in SHR-HF. Thus, in old SHR with advanced HHD there is profound structural and functional atrial remodeling. The occurrence of HF in SHR is associated with LA and RA hypertrophy, increased atrial fibrosis, impaired atrial myocyte contractility and SR Ca2+ handling and increased propensity for arrhythmogenic Ca2+ release. Therefore, functional remodeling intrinsic to atrial myocytes may contribute to the transition from compensated LV hypertrophy to HF in advanced HHD and an increased propensity of atrial arrhythmias in HF.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

The angiotensin receptor-associated protein Atrap is a stimulator of the cardiac Ca2+-ATPase SERCA2a

Katharina Mederle, Bernhard Gess, Florentina Pluteanu, Jelena Plackic, Klaus-Juergen Tiefenbach, Alexandra Grill, Jens Kockskaemper, Hayo Castrop

CARDIOVASCULAR RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice

Beatrix Scholz, Jan Sebastian Schulte, Sabine Hamer, Kirsten Himmler, Florentina Pluteanu, Matthias Dodo Seidl, Juliane Stein, Eva Wardelmann, Elke Hammer, Uwe Voelker, Frank Ulrich Mueller

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)

Article Biochemistry & Molecular Biology

Annexin A4 N-terminal peptide inhibits adenylyl cyclase 5 and limits β-adrenoceptor-mediated prolongation of cardiac action potential

Alexander Heinick, Florentina Pluteanu, Christina Hermes, Andre Klemme, Manuel Domnik, Xenia Husser, Volker Gerke, Wilhelm Schmitz, Frank U. Mueller

FASEB JOURNAL (2020)

Article Biochemistry & Molecular Biology

Induction of ICER is superseded by smICER, challenging the impact of ICER under chronic beta-adrenergic stimulation

Matthias D. Seidl, Benedikt Fels, Daniel Kranick, Alexandra Sternberg, Kristina Grimm, Frank T. Stuempel, Florentina Pluteanu, Jan S. Schulte, Alexander Heinick, Nobuhiko Kojima, Shogo Endo, Andreas Huge, Monika Stoll, Frank U. Mueller

FASEB JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Inward Rectifier K+ Currents Contribute to the Proarrhythmic Electrical Phenotype of Atria Overexpressing Cyclic Adenosine Monophosphate Response Element Modulator Isoform CREM-IbΔC-X

Florentina Pluteanu, Matthias D. Seidl, Sabine Hamer, Beatrix Scholz, Frank U. Mueller

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

Activation of PKC results in improved contractile effects and Ca2+ cycling y inhibition of PP2A-B56α

Florentina Pluteanu, Peter Boknik, Alexander Heinick, Christiane Koenig, Frank U. Mueller, Adam Weidlich, Uwe Kirchhefer

Summary: The phosphorylation of B56 alpha at Ser(41) by PKC is involved in the regulation of myocyte Ca2+ cycling and contraction. PKC activation leads to a decrease in PP2A activity and an increase in myocyte contraction and intracellular Ca2+ signaling. PKC-mediated inhibition of PP2A also modulates the activation and inactivation kinetics of LTCC.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2022)

Letter Cardiac & Cardiovascular Systems

The PP2A pathway plays a crucial role in controlling cardiac physiology Reply

Florentina Pluteanu, Uwe Kirchhefer

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2022)

Review Cell Biology

Left Atrial Myocardium in Arterial Hypertension

Jens Kockskaemper, Florentina Pluteanu

Summary: Arterial hypertension affects approximately 1 billion people worldwide, resulting in increased morbidity and mortality. In addition to cardiac damage such as left ventricular hypertrophy, dysfunction, and heart failure, hypertension also causes left atrial remodeling, potentially leading to atrial contractile dysfunction and atrial fibrillation. This review examines the various aspects of left atrial remodeling in hypertension, identifying potential mechanisms and discussing its consequences for atrial and ventricular function.

CELLS (2022)

Meeting Abstract Pharmacology & Pharmacy

Chronically isoproterenol-stimulated annexin A4 deficient mice developed earlier electrical remodeling and hypertrophy at cellular level

F. Pluteanu, M. Domnik, C. Rolfes, A. Klemme, A. Heinick, F. U. Mueller

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)

Meeting Abstract Pharmacology & Pharmacy

Regulation of the beta- adrenergic pathway and cardiac annexins in anxA4a-/- gene-trap mice chronically stimulated with isoproterenol

M. Domnik, F. Pluteanu, C. Rolfes, A. Klemme, A. Heinick, F. U. Mueller

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)

Meeting Abstract Cardiac & Cardiovascular Systems

Deletion of b56-alpha, a regulatory subunit of protein phosphatase 2a, is associated with an increased propensity to arrhythmia

D. Glaser, F. Pluteanu, A. Heinick, F. U. Mueller, P. Boknik, U. Kirchhefer

EUROPEAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

Characterization of the Genetic Program Linked to the Development of Atrial Fibrillation in CREM-IbΔC-X Mice

Matthias D. Seidl, Juliane Stein, Sabine Hamer, Florentina Pluteanu, Beatrix Scholz, Eva Wardelmann, Andreas Huge, Anika Witten, Monika Stoll, Elke Hammer, Uwe Voelker, Frank U. Mueller

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)

Meeting Abstract Pharmacology & Pharmacy

Characterization of the arrhythmogenic substrate in a mouse model before and after onset of atrial fibrillation

M. D. Seidl, J. Stein, S. Hamer, F. Pluteanu, B. Scholz, E. Wardelmann, A. Huge, A. Witten, M. Stoll, E. Hammer, U. Voelker, F. U. Mueller

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)

Meeting Abstract Pharmacology & Pharmacy

Ionic currents altered by atrial fibrillation onset in atrial myocytes of CREM-IbΔC-X transgenic mice

F. Pluteanu, M. Seidl, B. Scholz, S. Hamer, F. U. Mueller

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Epicardial deletion of Sox9 leads to myxomatous valve degeneration and identifies Cd109 as a novel gene associated with valve development

Andrew B. Harvey, Renelyn A. Woltes, Raymond N. Deepe, Hannah G. Tarolli, Jenna R. Drummond, Allison Trouten, Auva Zandi, Jeremy L. Barth, Rupak Mukherjee, Martin J. Romeo, Silvia G. Vaena, Ge Tao, Robin Muise-Helmericks, Paula S. Ramos, Russell A. Norris, Andy Wessels

Summary: This study highlights the importance of SOX9 in the regulation of epicardial cell invasion and emphasizes the role of EPDCs in regulating atrioventricular valve development and homeostasis. It also reports a novel expression profile of Cd109, a gene with previously unknown relevance in heart development.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Review Cardiac & Cardiovascular Systems

Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases

MariaSanta C. Mangione, Jinhua Wen, Dian J. Cao

Summary: mTOR, a mechanistic target of rapamycin, is an evolutionarily conserved pathway that plays a fundamental role in nutrient sensing, growth, metabolism, lifespan, and aging. Recent studies have highlighted the regulatory role of mTOR in innate immune responses and its involvement in the pathogenesis of cardiovascular diseases, especially in acute inflammation and atherosclerotic cardiovascular disease. This review also discusses mTOR's role in trained immunity, immune senescence, and clonal hematopoiesis, as well as its architecture and regulatory complexes.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Classification of regulatory T cells and their role in myocardial ischemia-reperfusion injury

Junlin Li, Yajun Gong, Yiren Wang, Huihui Huang, Huan Du, Lianying Cheng, Cui Ma, Yongxiang Cai, Hukui Han, Jianhong Tao, Gang Li, Panke Cheng

Summary: Myocardial ischemia-reperfusion injury is closely related to the final infarct size in acute myocardial infarction. Regulatory T cells play an important role in the inflammatory response after AMI, but different subtypes of Tregs have different effects on the injury.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

β-hydroxybutyrate administered at reperfusion reduces infarct size and preserves cardiac function by improving mitochondrial function through autophagy in male mice

Yuxin Chu, Yutao Hua, Lihao He, Jin He, Yunxi Chen, Jing Yang, Ismail Mahmoud, Fanfang Zeng, Xiaochang Zeng, Gloria A. Benavides, Victor M. Darley-Usmar, Martin E. Young, Scott W. Ballinger, Sumanth D. Prabhu, Cheng Zhang, Min Xie

Summary: This study demonstrates that administering beta-hydroxybutyrate (beta-OHB) at the time of reperfusion can reduce infarct size and preserve cardiac function by activating autophagy and preserving mitochondrial homeostasis, potentially through mTOR inhibition.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)